Cargando…
The role of epithelial membrane antigen (EMA) overexpression in the prognosis of prostatic adenocarcinoma
Prostatic adenocarcinoma is the second-most common cancer in men and the fifth most common cause of cancer death. Its incidence increases with age; 75% of patients are 65 years and older. The aim of the study was to assess epithelial membrane antigen (EMA) expression in prostatic adenocarcinoma as a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Carol Davila University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126468/ https://www.ncbi.nlm.nih.gov/pubmed/35646176 http://dx.doi.org/10.25122/jml-2021-0272 |